These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22949455)

  • 1. Medicare's payment strategy for end-stage renal disease now embraces bundled payment and pay-for-performance to cut costs.
    Swaminathan S; Mor V; Mehrotra R; Trivedi A
    Health Aff (Millwood); 2012 Sep; 31(9):2051-8. PubMed ID: 22949455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare's Bundled Payment Initiatives for Hospital-Initiated Episodes: Evidence and Evolution.
    Yee CA; Pizer SD; Frakt A
    Milbank Q; 2020 Sep; 98(3):908-974. PubMed ID: 32820837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing mandated health care reforms: the Affordable Care Act, accountable care organizations, and the Medicare ESRD program.
    Watnick S; Weiner DE; Shaffer R; Inrig J; Moe S; Mehrotra R;
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1535-43. PubMed ID: 22626961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lessons of Medicare's prospective payment system show that the bundled payment program faces challenges.
    Altman SH
    Health Aff (Millwood); 2012 Sep; 31(9):1923-30. PubMed ID: 22949439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism.
    Gupta C; Chertow GM; Linthicum MT; Van Nuys K; Belozeroff V; Quarles D; Lakdawalla DN
    Health Serv Res; 2014 Dec; 49(6):1925-43. PubMed ID: 25040130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare payment options for recombinant erythropoietin therapy.
    Sisk JE; Gianfrancesco FD; Coster JM
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):93-7. PubMed ID: 1928087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.
    Wang V; Coffman CJ; Sanders LL; Lee SD; Hirth RA; Maciejewski ML
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1833-1841. PubMed ID: 30455323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents.
    Swaminathan S; Mor V; Mehrotra R; Trivedi AN
    Health Serv Res; 2015 Jun; 50(3):790-808. PubMed ID: 25355431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
    Iglehart JK
    N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
    [No Abstract]   [Full Text] [Related]  

  • 12. What can we learn from the U.S. expanded end-stage renal disease bundle?
    Chambers JD; Weiner DE; Bliss SK; Neumann PJ
    Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
    Park H; Rascati KL; Keith MS
    J Manag Care Spec Pharm; 2015 Jun; 21(6):507-14. PubMed ID: 26011552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Policy and Kidney Care in the United States: Core Curriculum 2020.
    Mendu ML; Weiner DE
    Am J Kidney Dis; 2020 Nov; 76(5):720-730. PubMed ID: 32771281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
    Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
    Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician reimbursement for outpatient dialysis care: Past, present, and future.
    Anumudu SJ; Erickson KF
    Semin Dial; 2020 Jan; 33(1):68-74. PubMed ID: 31944418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Big things come in bundled packages: implications of bundled payment systems in health care reimbursement reform.
    Delisle DR
    Am J Med Qual; 2013; 28(4):339-44. PubMed ID: 23092934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Bundled Payments for Joint Replacement Surgery and Patient Outcomes With Simultaneous Hospital Participation in Accountable Care Organizations.
    Liao JM; Emanuel EJ; Venkataramani AS; Huang Q; Dinh CT; Shan EZ; Wang E; Zhu J; Cousins DS; Navathe AS
    JAMA Netw Open; 2019 Sep; 2(9):e1912270. PubMed ID: 31560389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebasing the Medicare payment for dialysis: rationale, challenges, and opportunities.
    Wish D; Johnson D; Wish J
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2195-202. PubMed ID: 25189926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.